Sorafenib-induced severe acute hepatitis in a stable liver transplant recipient

Transplantation. 2010 Jul 15;90(1):98-9. doi: 10.1097/TP.0b013e3181daac69.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Benzenesulfonates / adverse effects*
  • Benzenesulfonates / therapeutic use
  • Bilirubin / blood
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / surgery*
  • Chemical and Drug Induced Liver Injury / diagnosis*
  • Hepatitis C / surgery*
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / surgery*
  • Liver Transplantation / immunology*
  • Male
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Sorafenib
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib
  • Bilirubin